Biotechs Lead Wave Of New IPOs Filling June Pipeline

Law360 (May 25, 2018, 7:48 PM EDT) -- A wave of venture-backed biotechnology and health care companies are lining up initial public offerings that could price in June, including at least eight that filed plans during the week of May 21, leading more than a dozen IPO prospects set to reignite deal flow in the coming weeks.

Eidos Therapeutics Inc. and Avrobio Inc., which are developing therapies to treat rare diseases, filed IPOs on Friday that are estimated to raise $115 million and $86 million, respectively. Both companies are represented by Goodwin Procter LLP. Eidos and Avrobio were preceded by three biotechnology firms that filed IPOs on Thursday hoping...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!